| Study summary: |
|
Study to evaluate a sleep drug currently approved for adults 18 and older but is investigational for children ages 6 to 17. |
| Qualified participants must: |
|
• Be diagnosed with ADHD
•
Be 6 to 17 years of age
•
Be experiencing sleep problems for at least 3 months
•
Have had sleep problems that specifically cause difficulty with falling asleep and/or staying asleep
|
| Participants will receive: |
|
Study related care, clinic visits, sleep tests, medical assessments, study drug, study related monitoring by research healthcare providers, possible reimbursement for time and travel, and an opportunity to learn more about your child's sleep problem. |